FAK inhibitor treatment systemically regulates the glioblastoma immune environment via blocking monocyte trafficking
Emily R. Webb, A. R. S. Black, Giovana Carrasco, Muhammad Furqan, Robert L. Hollis, Alexander E.P. Loftus, Joel A Ochoa, Romain Enjalbert, Tara Best, Xiaozhong Peng, Morwenna Muir, Fraser Laing, Martin W. Lee, Sofian Al Shboul, Tongjie Wang, , Valerie G. Brunton
This study shows that systemic FAK inhibition reduces immunosuppressive macrophages in glioblastoma by blocking monocyte trafficking, enhancing T cell activity and improving survival in a mouse model.
bioRxiv · Nov 26, 2025 · PreprintImmunology